1,171 Shares in Humana Inc. (NYSE:HUM) Bought by Horizon Advisory Services Inc.

Horizon Advisory Services Inc. purchased a new stake in shares of Humana Inc. (NYSE:HUM) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,171 shares of the insurance provider’s stock, valued at approximately $297,000.

Several other hedge funds have also bought and sold shares of the stock. Pinnacle Wealth Management Advisory Group LLC grew its holdings in Humana by 3.6% during the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock valued at $272,000 after purchasing an additional 37 shares during the period. Atlas Brown Inc. grew its holdings in Humana by 0.6% during the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after purchasing an additional 38 shares during the period. Moors & Cabot Inc. grew its holdings in Humana by 2.5% during the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after purchasing an additional 40 shares during the period. Mather Group LLC. grew its holdings in Humana by 21.0% during the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after purchasing an additional 41 shares during the period. Finally, Capital Advisors Ltd. LLC grew its holdings in Humana by 26.1% during the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock valued at $53,000 after purchasing an additional 43 shares during the period. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Barclays boosted their price target on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. TD Cowen boosted their price objective on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Royal Bank of Canada restated an “outperform” rating and issued a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. JPMorgan Chase & Co. lowered their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. Finally, Piper Sandler boosted their price objective on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, Humana has a consensus rating of “Hold” and an average target price of $285.68.

Insider Buying and Selling at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.32% of the company’s stock.

Humana Trading Down 0.3 %

Shares of HUM stock opened at $255.02 on Tuesday. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The stock’s 50 day simple moving average is $269.30 and its two-hundred day simple moving average is $288.93. The company has a market cap of $30.77 billion, a PE ratio of 25.63, a price-to-earnings-growth ratio of 2.05 and a beta of 0.56.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.39%. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.